IG 271 1.25mg (Ramipril 1.25 mg)
This pill with imprint "IG 271 1.25mg" is Yellow, Capsule-shape and has been identified as Ramipril 1.25 mg. It is supplied by InvaGen Pharmaceuticals, Inc..
Ramipril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; cardiovascular risk reduction; heart failure (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- IG 271 1.25mg
- 1.25 mg
- Prescription only
- Drug Class:
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- InvaGen Pharmaceuticals, Inc.
- Inactive Ingredients:
- pregelatinized starch
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about ramipril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 53 Reviews – Add your own review/rating
- Drug class: Angiotensin Converting Enzyme Inhibitors
Other brands: Altace
Related treatment guides
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.